RNAGene Inc.
PrivateLast Round
Series A
Extension
Oct 8, 2024
Total Funding Raised
$1.47M
Company Overview
RNAGene Inc. is a biotechnology company that develops mRNA-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNAGene Inc. Comparables
Compare RNAGene Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vernal Biosciences | 77% | |
| GenScript | 71% | |
| GeneOne Life Science Inc | 70% |
RNAGene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 8, 2024 |
RNAGene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel Lounge | Series A Extension |
| AI Angel Club | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2024
$1.47M round from AI Angel Club and Angel Lounge.
RNAGene Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RNAGene Inc.'s valuation, stock price, and market status.
Is RNAGene Inc. a public or private company?
RNAGene Inc. is a private company.
What is the current stock price of RNAGene Inc.?
RNAGene Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is RNAGene Inc. worth (valuation)?
Valuation information for RNAGene Inc. is not publicly available.
Can I buy RNAGene Inc. stock?
RNAGene Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RNAGene Inc.'s last funding round?
RNAGene Inc.'s most recent funding round was Series A Extension on October 8, 2024.
Who are the main investors in RNAGene Inc.?
Key investors in RNAGene Inc. include Angel Lounge, AI Angel Club.
Will RNAGene Inc. IPO soon?
No public IPO plans have been announced for RNAGene Inc..
How can I track RNAGene Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RNAGene Inc.'s secondary market activity and sign up for updates.